Marijuana Bill C-45 is right on track, GMP Securities says

The ride ahead may be a little bumpier, but GMP Securities analyst Martin Landry says Bill C-45 should meet its expected timeline.

On Monday, marijuana Bill C-45, by a vote of 200-82, passed the House of Commons Third Reading. The bill will now move to the senate.

“We’re one step closer to legalizing & regulating marijuana. #BillC45 means less money for organized crime and harder access for our kids. Tonight, it passed third reading in the House and it’s now headed to the Senate,” Canadian Prime Minister Justin Trudeau tweeted.

Landry says this was an expected developement and says the true test lies in the senate, where things are not expected to progress quite as smoothly.

“Unlike the HoC, there is no party majority within the Senate as Trudeau ejected several Liberal senators in 2014 in an effort to reduce partisanship,” the analyst explains. “The Senate’s current composition is ~16% Liberal, ~37% Conservative, and ~47% Independent which could suggest less potential consensus and hence, a less smooth progression for Bill C-45 through the Senate stage. We note however, various industry reports point to Independent senators often voting alongside the government, which is reassuring in our view as this could make the Independents the swing vote.”

Landry notes the senate will be on recess for the last week of December and for most of January, and that the bill will need to pass a first reading, second reading and vote, commitee review, report stage, and a third reading and vote to make its way through the senate. While the analyst says this will make for slower progress than the House of Commons, he expects the timelines have not changed.

“In our view, Bill C-45 has progressed quite well thus far without any major delays, and Third Reading passing within our expected November timeframe,” Landry says. “This represents a positive step through the legislative process, and supports our sector investment thesis. While movement through the Senate is expected to be less rapid, we believe there is enough time for the Senate review to be completed and Bill C-45 to be signed into law by July 1st, 2018.”

Canada is widely expected to become the first G20 nation to legalize access to cannabis for recreational purposes.

More Cantech Cannabis

Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

NTG Clarity Networks is a buy, this analyst says

In a March 31 initiation, Ventum Capital Markets analyst Amr Ezzat launched coverage of NTG Clarity Networks (NTG Clarity Networks… [Read More]

12 minutes ago

Uber is much more than you think, this investor says

In an appearance on BNN Bloomberg Market Call on March 31, Propellus Wealth Partners portfolio manager and senior wealth advisor… [Read More]

3 hours ago

Canadian economy is on firmer footing than expected: RBC

In a March 31 report, RBC economist Abbey Xu said the Canadian economy started 2026 on firmer footing than expected,… [Read More]

3 hours ago

Should you sell your zSpace stock?

In a March 31 report, Roth Capital Markets analyst Rohit Kulkarni maintained his “Buy” rating on zSpace (zSpace Stock Quote,… [Read More]

7 hours ago

Should you sell your Rezolve AI stock?

In a March 31 report, Roth Capital Markets analyst Rohit Kulkarni maintained his “Buy” rating on Rezolve AI (Rezolve AI… [Read More]

21 hours ago

This Canadian aerospace stock is a buy, TD says

In a March 31 note, TD Cowen analyst Tim James maintained his “Buy” rating on Magellan Aerospace (Magellan Aerospace Stock… [Read More]

21 hours ago